Making pediatric cancer more 'visible' boosts immunotherapy response
High-risk neuroblastoma is one of the most aggressive forms of solid tumors affecting children, originating in the nervous system. While a newer class of targeted immunotherapy drugs has improved survival ...
5 Oct 20:00 · Medical Xpress